Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease

Condition:   Alzheimer Disease Interventions:   Drug: neflamapimod;   Other: placebo Sponsors:   EIP Pharma, LLC;   Worldwide Clinical Trials;   VU University Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials